Related Experiment Video

Updated: Aug 9, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors

Michael J Mastrangelo1, Edmund C Lattime

  • 1Department of Medicine, Division of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Cancer Gene Therapy
|January 11, 2003
PubMed

Insights

Recombinant poxviruses show promise as cancer immunotherapies. By delivering immune-stimulating genes directly to tumors, they aim to enhance the body's natural defenses against cancer.

Area of Science:

  • Oncolytic virology
  • Cancer immunotherapy
  • Viral vector technology

Background:

  • Viruses are being investigated as antitumor agents using various strategies.
  • Recombinant viruses encoding toxins or prodrugs show direct antitumor activity.
  • A key limitation for systemic viral therapy is the lack of tumor-targeting constructs for metastatic disease.

Purpose of the Study:

  • To review preclinical and clinical data on recombinant poxviruses as vectors for cancer treatment.
  • To explore the use of poxviruses for in situ tumor transfection with immune-enhancing agents.
  • To hypothesize the potential of this approach in generating a systemic antitumor immune response.

Main Methods:

  • Review of preclinical and clinical studies involving recombinant poxviruses.
  • Analysis of poxvirus vector strategies for delivering immune-modulating genes.
  • Evaluation of data supporting in situ tumor transfection for immune enhancement.

Main Results:

  • Poxviruses can be engineered as vectors for expressing tumor antigens and cytokines.
  • Recombinant poxviruses demonstrate potential for in situ tumor transfection.
  • This strategy aims to enhance immune recognition and response against tumors.

Conclusions:

  • Recombinant poxviruses offer a promising strategy for cancer immunotherapy.
  • In situ tumor transfection with immune-enhancing agents can stimulate a systemic antitumor response.
  • This approach may lead to the eradication of primary and metastatic tumors.

More Related Videos

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...